The DOI matches its Crossref record; 248 of the 248 references it cites were found in a registry or an index.
NF-κB: At the Borders of Autoimmunity and Inflammation
Open accessAbstract
The transcription factor NF-κB regulates multiple aspects of innate and adaptive immune functions and serves as a pivotal mediator of inflammatory response. In the first part of this review, we discuss the NF-κB inducers, signaling pathways, and regulators involved in immune homeostasis as well as detail the importance of post-translational regulation by ubiquitination in NF-κB function. We also indicate the stages of central and peripheral tolerance where NF-κB plays a fundamental role. With respect to central tolerance, we detail how NF-κB regulates medullary thymic epithelial cell (mTEC) development, homeostasis, and function. Moreover, we elaborate on its role in the migration of double-positive (DP) thymocytes from the thymic cortex to the medulla. With respect to peripheral tolerance, we outline how NF-κB contributes to the inactivation and destruction of autoreactive T and B lymphocytes as well as the differentiation of CD4+-T cell subsets that are implicated in immune tolerance. In the latter half of the review, we describe the contribution of NF-κB to the pathogenesis of autoimmunity and autoinflammation. The recent discovery of mutations involving components of the pathway has both deepened our understanding of autoimmune disease and informed new therapeutic approaches to treat these illnesses.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Adverse Renal Effects of Immune Checkpoint Inhibitors: A Narrative Review
Wanchoo, R., Karam, S., Uppal, N. N., Barta, V. S., Deray, G., Devoe, C., Launay-Vacher, V., Jhaveri, K. D., & on behalf of Cancer and Kidney International Network Workgroup on Immune Checkpoint Inhibitors (2017) · American Journal of Nephrology · doi:10.1159/000455014 · Cited by 15,256
NF-κB signaling in inflammation
Liu, T., Zhang, L., Joo, D., & Sun, S.-C. (2017) · Signal Transduction and Targeted Therapy · doi:10.1038/sigtrans.2017.23 · Cited by 8,791
Differentiation of Effector CD4 T Cell Populations
Zhu, J., Yamane, H., & Paul, W. E. (2010) · Annual Review of Immunology · doi:10.1146/annurev-immunol-030409-101212 · Cited by 3,452
Activation and regulation of the inflammasomes
Latz, E., Xiao, T. S., & Stutz, A. (2013) · Nature Reviews Immunology · doi:10.1038/nri3452 · Cited by 2,884
The NF- B Family of Transcription Factors and Its Regulation
Oeckinghaus, A., & Ghosh, S. (2009) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a000034 · Cited by 2,842
Nod2 Is a General Sensor of Peptidoglycan through Muramyl Dipeptide (MDP) Detection
Girardin, S. E., Boneca, I. G., Viala, J., Chamaillard, M., Labigne, A., Thomas, G., Philpott, D. J., & Sansonetti, P. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.c200651200 · Cited by 2,408
Auphan, N., DiDonato, J. A., Rosette, C., Helmberg, A., & Karin, M. (1995) · Science · doi:10.1126/science.270.5234.286 · Cited by 2,390
Integrating cell-signalling pathways with NF-κB and IKK function
Perkins, N. D. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2083 · Cited by 2,350
Roles of the immune system in cancer: From tumor initiation to metastatic progression
Gonzalez, H., Hagerling, C., & Werb, Z. (2018) · Genes & Development · doi:10.1101/gad.314617.118 · Cited by 2,111
Predominant Autoantibody Production by Early Human B Cell Precursors
Wardemann, H., Yurasov, S., Schaefer, A., Young, J. W., Meffre, E., & Nussenzweig, M. C. (2003) · Science · doi:10.1126/science.1086907 · Cited by 2,083
IKK-1 and IKK-2: Cytokine-Activated IκB Kinases Essential for NF-κB Activation
Mercurio, F., Zhu, H., Murray, B. W., Shevchenko, A., Bennett, B. L., Li, J. W., Young, D. B., Barbosa, M., Mann, M., Manning, A., et al. (1997) · Science · doi:10.1126/science.278.5339.860 · Cited by 2,040
Tumor angiogenesis: causes, consequences, challenges and opportunities
Lugano, R., Ramachandran, M., & Dimberg, A. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03351-7 · Cited by 1,986
30 Years of NF-κB: A Blossoming of Relevance to Human Pathobiology
Zhang, Q., Lenardo, M. J., & Baltimore, D. (2017) · Cell · doi:10.1016/j.cell.2016.12.012 · Cited by 1,982
Terzić, J., Grivennikov, S., Karin, E., & Karin, M. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.01.058 · Cited by 1,974
Targeting the NLRP3 inflammasome in inflammatory diseases
Mangan, M. S. J., Olhava, E. J., Roush, W. R., Seidel, H. M., Glick, G. D., & Latz, E. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.97 · Cited by 1,885 · cited 7×
“Activation of the NLRP3 inflammasome, a multiprotein complex, leads to caspase activation with production of proinflammatory IL-1b.”
BackgroundInfluentialInhibition of NF-κB by Sodium Salicylate and Aspirin
Kopp, E., & Ghosh, S. (1994) · Science · doi:10.1126/science.8052854 · Cited by 1,753
The anti-inflammatory agents aspirin and salicylate inhibit the activity of IκB kinase-β
Yin, M.-J., Yamamoto, Y., & Gaynor, R. B. (1998) · Nature · doi:10.1038/23948 · Cited by 1,590
Mice Transgenic for Baff Develop Lymphocytic Disorders along with Autoimmune Manifestations
Mackay, F., Woodcock, S. A., Lawton, P., Ambrose, C., Baetscher, M., Schneider, P., Tschopp, J., & Browning, J. L. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.11.1697 · Cited by 1,480
McDermott, M. F., Aksentijevich, I., Galon, J., McDermott, E. M., Ogunkolade, B. W., Centola, M., Mansfield, E., Gadina, M., Karenko, L., Pettersson, T., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)80721-7 · Cited by 1,408
Immature, semi-mature and fully mature dendritic cells: which signals induce tolerance or immunity?
Lutz, M. B., & Schuler, G. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02281-0 · Cited by 1,349
Lymphokine Production by Human T Cells in Disease States
Romagnani, S. (1994) · Annual Review of Immunology · doi:10.1146/annurev.immunol.12.1.227 · Cited by 1,343
Chamaillard, M., Hashimoto, M., Horie, Y., Masumoto, J., Qiu, S., Saab, L., Ogura, Y., Kawasaki, A., Fukase, K., Kusumoto, S., et al. (2003) · Nature Immunology · doi:10.1038/ni945 · Cited by 1,323
Kojima, K., Takata, A., Vadnais, C., Otsuka, M., Yoshikawa, T., Akanuma, M., Kondo, Y., Kang, Y. J., Kishikawa, T., Kato, N., et al. (2012) · Nature Communications · doi:10.1038/ncomms2081 · Cited by 1,283
Targeted disruption of the p50 subunit of NF-κB leads to multifocal defects in immune responses
Sha, W. C., Liou, H.-C., Tuomanen, E. I., & Baltimore, D. (1995) · Cell · doi:10.1016/0092-8674(95)90415-8 · Cited by 1,157
Glucose-induced β cell production of IL-1β contributes to glucotoxicity in human pancreatic islets
Maedler, K., Sergeev, P., Ris, F., Oberholzer, J., Joller-Jemelka, H. I., Spinas, G. A., Kaiser, N., Halban, P. A., & Donath, M. Y. (2017) · Journal of Clinical Investigation · doi:10.1172/jci92172 · Cited by 1,114
Proinflammatory Cytokines in the Pathogenesis of Inflammatory Bowel Diseases
Strober, W., & Fuss, I. J. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.02.016 · Cited by 1,102
Ray, A., & Prefontaine, K. E. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.2.752 · Cited by 1,064
Glucose-induced β cell production of IL-1β contributes to glucotoxicity in human pancreatic islets
Maedler, K., Sergeev, P., Ris, F., Oberholzer, J., Joller-Jemelka, H. I., Spinas, G. A., Kaiser, N., Halban, P. A., & Donath, M. Y. (2002) · Journal of Clinical Investigation · doi:10.1172/jci200215318 · Cited by 1,005
Interleukin-36–Receptor Antagonist Deficiency and Generalized Pustular Psoriasis
Marrakchi, S., Guigue, P., Renshaw, B. R., Puel, A., Pei, X.-Y., Fraitag, S., Zribi, J., Bal, E., Cluzeau, C., Chrabieh, M., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1013068 · Cited by 998
New therapies for treatment of rheumatoid arthritis
Smolen, J. S., Aletaha, D., Koeller, M., Weisman, M. H., & Emery, P. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60784-3 · Cited by 995
An Autoinflammatory Disease with Deficiency of the Interleukin-1–Receptor Antagonist
Aksentijevich, I., Masters, S. L., Ferguson, P. J., Dancey, P., Frenkel, J., van Royen-Kerkhoff, A., Laxer, R., Tedgård, U., Cowen, E. W., Pham, T.-H., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0807865 · Cited by 987
Effect of friction on oxidative graphite intercalation and high-quality graphene formation
Seiler, S., Halbig, C. E., Grote, F., Rietsch, P., Börrnert, F., Kaiser, U., Meyer, B., & Eigler, S. (2018) · Nature Communications · doi:10.1038/s41467-018-03211-1 · Cited by 969
Severe Liver Degeneration in Mice Lacking the IκB Kinase 2 Gene
Li, Q., Antwerp, D. V., Mercurio, F., Lee, K.-F., & Verma, I. M. (1999) · Science · doi:10.1126/science.284.5412.321 · Cited by 963
IKK-γ is an essential regulatory subunit of the IκB kinase complex
Rothwarf, D. M., Zandi, E., Natoli, G., & Karin, M. (1998) · Nature · doi:10.1038/26261 · Cited by 957
Linear ubiquitination prevents inflammation and regulates immune signalling
Gerlach, B., Cordier, S. M., Schmukle, A. C., Emmerich, C. H., Rieser, E., Haas, T. L., Webb, A. I., Rickard, J. A., Anderton, H., Wong, W. W.-L., et al. (2011) · Nature · doi:10.1038/nature09816 · Cited by 940
Han, J.-W., Zheng, H.-F., Cui, Y., Sun, L.-D., Ye, D.-Q., Hu, Z., Xu, J.-H., Cai, Z.-M., Huang, W., Zhao, G.-P., et al. (2009) · Nature Genetics · doi:10.1038/ng.472 · Cited by 936
Li, Z.-W., Chu, W., Hu, Y., Delhase, M., Deerinck, T., Ellisman, M., Johnson, R., & Karin, M. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.11.1839 · Cited by 926
X-linked anhidrotic ectodermal dysplasia with immunodeficiency is caused by impaired NF-κB signaling
Döffinger, R., Smahi, A., Bessia, C., Geissmann, F., Feinberg, J., Durandy, A., Bodemer, C., Kenwrick, S., Dupuis-Girod, S., Blanche, S., et al. (2001) · Nature Genetics · doi:10.1038/85837 · Cited by 828
Abnormal Morphogenesis But Intact IKK Activation in Mice Lacking the IKKα Subunit of IκB Kinase
Hu, Y., Baud, V., Delhase, M., Zhang, P., Deerinck, T., Ellisman, M., Johnson, R., & Karin, M. (1999) · Science · doi:10.1126/science.284.5412.316 · Cited by 823
Wehkamp, J., Harder, J., Weichenthal, M., Schwab, M., Schäffeler, E., Schlee, M., Herrlinger, K. R., Stallmach, A., Noack, F., Fritz, P., et al. (2004) · Gut · doi:10.1136/gut.2003.032805 · Cited by 823
Interleukin-18 Binding Protein
Novick, D., Kim, S.-H., Fantuzzi, G., Reznikov, L. L., Dinarello, C. A., & Rubinstein, M. (1999) · Immunity · doi:10.1016/s1074-7613(00)80013-8 · Cited by 779
Genomic rearrangement in NEMO impairs NF-κB activation and is a cause of incontinentia pigmenti
The International Incontinentia Pigmenti (IP) Consortium (2000) · Nature · doi:10.1038/35013114 · Cited by 750
SHARPIN forms a linear ubiquitin ligase complex regulating NF-κB activity and apoptosis
Ikeda, F., Deribe, Y. L., Skånland, S. S., Stieglitz, B., Grabbe, C., Franz-Wachtel, M., van Wijk, S. J. L., Goswami, P., Nagy, V., Terzic, J., et al. (2011) · Nature · doi:10.1038/nature09814 · Cited by 745
Specific Recognition of Linear Ubiquitin Chains by NEMO Is Important for NF-κB Activation
Rahighi, S., Ikeda, F., Kawasaki, M., Akutsu, M., Suzuki, N., Kato, R., Kensche, T., Uejima, T., Bloor, S., Komander, D., et al. (2009) · Cell · doi:10.1016/j.cell.2009.03.007 · Cited by 744
Self-RNA–antimicrobial peptide complexes activate human dendritic cells through TLR7 and TLR8
Ganguly, D., Chamilos, G., Lande, R., Gregorio, J., Meller, S., Facchinetti, V., Homey, B., Barrat, F. J., Zal, T., & Gilliet, M. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20090480 · Cited by 740
The Regulation of NF-κB Subunits by Phosphorylation
Christian, F., Smith, E., & Carmody, R. (2016) · Cells · doi:10.3390/cells5010012 · Cited by 717
Worthey, E. A., Mayer, A. N., Syverson, G. D., Helbling, D., Bonacci, B. B., Decker, B., Serpe, J. M., Dasu, T., Tschannen, M. R., Veith, R. L., et al. (2011) · Genetics in Medicine · doi:10.1097/gim.0b013e3182088158 · Cited by 711
Chun, H. J., Zheng, L., Ahmad, M., Wang, J., Speirs, C. K., Siegel, R. M., Dale, J. K., Puck, J., Davis, J., Hall, C. G., et al. (2002) · Nature · doi:10.1038/nature01063 · Cited by 708
May, M. J., D'Acquisto, F., Madge, L. A., Glöckner, J., Pober, J. S., & Ghosh, S. (2000) · Science · doi:10.1126/science.289.5484.1550 · Cited by 680
Zhou, Q., Wang, H., Schwartz, D. M., Stoffels, M., Park, Y. H., Zhang, Y., Yang, D., Demirkaya, E., Takeuchi, M., Tsai, W. L., et al. (2016) · Nature Genetics · doi:10.1038/ng.3459 · Cited by 642
The role of defective clearance of apoptotic cells in systemic autoimmunity
Muñoz, L. E., Lauber, K., Schiller, M., Manfredi, A. A., & Herrmann, M. (2010) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2010.46 · Cited by 627
The immunogenetics of Psoriasis: A comprehensive review
Harden, J. L., Krueger, J. G., & Bowcock, A. M. (2015) · Journal of Autoimmunity · doi:10.1016/j.jaut.2015.07.008 · Cited by 616
SHARPIN is a component of the NF-κB-activating linear ubiquitin chain assembly complex
Tokunaga, F., Nakagawa, T., Nakahara, M., Saeki, Y., Taniguchi, M., Sakata, S.-I., Tanaka, K., Nakano, H., & Iwai, K. (2011) · Nature · doi:10.1038/nature09815 · Cited by 609 · cited 2×
“Furthermore, mutant mice lacking SHARPIN develop severe autoinflammatory diseases (severe dermatitis and system-wide organ inflammation) and immunodeficiency due to destabilization of the two remaining LUBAC subunits (23, 64, 184).”
BackgroundLimb and Skin Abnormalities in Mice Lacking IKKα
Takeda, K., Takeuchi, O., Tsujimura, T., Itami, S., Adachi, O., Kawai, T., Sanjo, H., Yoshikawa, K., Terada, N., & Akira, S. (1999) · Science · doi:10.1126/science.284.5412.313 · Cited by 609
Genetic variants near TNFAIP3 on 6q23 are associated with systemic lupus erythematosus
Graham, R. R., Cotsapas, C., Davies, L., Hackett, R., Lessard, C. J., Leon, J. M., Burtt, N. P., Guiducci, C., Parkin, M., Gates, C., et al. (2008) · Nature Genetics · doi:10.1038/ng.200 · Cited by 588
Inducible nitric oxide synthase in human diseases
Kröncke, K.-D., Fehsel, K., & Kolb-Bachofen, V (2001) · Clinical and Experimental Immunology · doi:10.1046/j.1365-2249.1998.00648.x · Cited by 585
Reduced Competitiveness of Autoantigen-Engaged B Cells due to Increased Dependence on BAFF
Lesley, R., Xu, Y., Kalled, S. L., Hess, D. M., Schwab, S. R., Shu, H.-B., & Cyster, J. G. (2004) · Immunity · doi:10.1016/s1074-7613(04)00079-2 · Cited by 577
T-Cell Tolerance: Central and Peripheral
Xing, Y., & Hogquist, K. A. (2012) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a006957 · Cited by 576
Jeremiah, N., Neven, B., Gentili, M., Callebaut, I., Maschalidi, S., Stolzenberg, M.-C., Goudin, N., Frémond, M.-L., Nitschke, P., Molina, T. J., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci79100 · Cited by 562
Self-citationBurke, J. R., Pattoli, M. A., Gregor, K. R., Brassil, P. J., MacMaster, J. F., McIntyre, K. W., Yang, X., Iotzova, V. S., Clarke, W., Strnad, J., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209677200 · Cited by 550
Onoufriadis, A., Simpson, M. A., Pink, A. E., Di Meglio, P., Smith, C. H., Pullabhatla, V., Knight, J., Spain, S. L., Nestle, F. O., Burden, A. D., et al. (2011) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2011.07.022 · Cited by 529
Severe liver degeneration and lack of NF-kappaB activation in NEMO/IKKgamma-deficient mice.
Rudolph, D., Yeh, W., Wakeham, A. C., Rudolph, B., Nallainathan, D., Potter, J., Elia, A., & Mak, T. W. (2000) · PubMed · Cited by 528
Zonana, J., Elder, M. E., Schneider, L. C., Orlow, S. J., Moss, C., Golabi, M., Shapira, S. K., Farndon, P. A., Wara, D. W., Emmal, S. A., et al. (2000) · The American Journal of Human Genetics · doi:10.1086/316914 · Cited by 521
Das, J., Chen, C.-H., Yang, L., Cohn, L., Ray, P., & Ray, A. (2001) · Nature Immunology · doi:10.1038/83158 · Cited by 518
A single NFκB system for both canonical and non-canonical signaling
Shih, V. F.-S., Tsui, R., Caldwell, A., & Hoffmann, A. (2011) · Cell Research · doi:10.1038/cr.2010.161 · Cited by 499
A20 in inflammation and autoimmunity
Catrysse, L., Vereecke, L., Beyaert, R., & van Loo, G. (2014) · Trends in Immunology · doi:10.1016/j.it.2013.10.005 · Cited by 493
Caldenhoven, E., Liden, J., Wissink, S., Van de Stolpe, A., Raaijmakers, J., Koenderman, L., Okret, S., Gustafsson, J. A., & Van der Saag, P. T. (1995) · Molecular Endocrinology · doi:10.1210/mend.9.4.7659084 · Cited by 489
OTULIN Antagonizes LUBAC Signaling by Specifically Hydrolyzing Met1-Linked Polyubiquitin
Keusekotten, K., Elliott, P. R., Glockner, L., Fiil, B. K., Damgaard, R. B., Kulathu, Y., Wauer, T., Hospenthal, M. K., Gyrd-Hansen, M., Krappmann, D., et al. (2013) · Cell · doi:10.1016/j.cell.2013.05.014 · Cited by 482
Severe liver degeneration and lack of NF-κ B activation in NEMO/IKKγ-deficient mice
Rudolph, D., Yeh, W.-C., Wakeham, A., Rudolph, B., Nallainathan, D., Potter, J., Elia, A. J., & Mak, T. W. (2000) · Genes & Development · doi:10.1101/gad.14.7.854 · Cited by 479
Cyld Inhibits Tumor Cell Proliferation by Blocking Bcl-3-Dependent NF-κB Signaling
Massoumi, R., Chmielarska, K., Hennecke, K., Pfeifer, A., & Fässler, R. (2006) · Cell · doi:10.1016/j.cell.2006.03.041 · Cited by 476
Boisson, B., Laplantine, E., Prando, C., Giliani, S., Israelsson, E., Xu, Z., Abhyankar, A., Israël, L., Trevejo-Nunez, G., Bogunovic, D., et al. (2012) · Nature Immunology · doi:10.1038/ni.2457 · Cited by 474
Self-citationBeg, A. A., Sha, W. C., Bronson, R. T., & Baltimore, D. (1995) · Genes & Development · doi:10.1101/gad.9.22.2736 · Cited by 473
Mechanisms maintaining peripheral tolerance
Mueller, D. L. (2010) · Nature Immunology · doi:10.1038/ni.1817 · Cited by 461
NEMO/IKKγ-Deficient Mice Model Incontinentia Pigmenti
Schmidt-Supprian, M., Bloch, W., Courtois, G., Addicks, K., Israël, A., Rajewsky, K., & Pasparakis, M. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)80263-4 · Cited by 437
Rodero, M. P., & Crow, Y. J. (2016) · Journal of Experimental Medicine · doi:10.1084/jem.20161596 · Cited by 433
Activation of the canonical IKK complex by K63/M1-linked hybrid ubiquitin chains
Emmerich, C. H., Ordureau, A., Strickson, S., Arthur, J. S. C., Pedrioli, P. G. A., Komander, D., & Cohen, P. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1314715110 · Cited by 431
Requirement for Caspase-8 in NF-κB Activation by Antigen Receptor
Su, H., Bidère, N., Zheng, L., Cubre, A., Sakai, K., Dale, J., Salmena, L., Hakem, R., Straus, S., & Lenardo, M. (2005) · Science · doi:10.1126/science.1104765 · Cited by 429
Transcriptional regulation by STAT6
Goenka, S., & Kaplan, M. H. (2011) · Immunologic Research · doi:10.1007/s12026-011-8205-2 · Cited by 429
CD1d-restricted iNKT cells, the ‘Swiss-Army knife’ of the immune system
Matsuda, J. L., Mallevaey, T., Scott-Browne, J., & Gapin, L. (2008) · Current Opinion in Immunology · doi:10.1016/j.coi.2008.03.018 · Cited by 407
Makris, C., Godfrey, V. L., Krähn-Senftleben, G., Takahashi, T., Roberts, J. L., Schwarz, T., Feng, L., Johnson, R. S., & Karin, M. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)80262-2 · Cited by 395
Caamaño, J. H., Rizzo, C. A., Durham, S. K., Barton, D. S., Raventós-Suárez, C., Snapper, C. M., & Bravo, R. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.2.185 · Cited by 395
The family of the interleukin‐1 receptors
Boraschi, D., Italiani, P., Weil, S., & Martin, M. U. (2018) · Immunological Reviews · doi:10.1111/imr.12606 · Cited by 389
Development of Foxp3+ Regulatory T Cells Is Driven by the c-Rel Enhanceosome
Ruan, Q., Kameswaran, V., Tone, Y., Li, L., Liou, H.-C., Greene, M. I., Tone, M., & Chen, Y. H. (2009) · Immunity · doi:10.1016/j.immuni.2009.10.006 · Cited by 378
Glucose Induces β-Cell Apoptosis Via Upregulation of the Fas Receptor in Human Islets
Maedler, K., Spinas, G. A., Lehmann, R., Sergeev, P., Weber, M., Fontana, A., Kaiser, N., & Donath, M. Y. (2001) · Diabetes · doi:10.2337/diabetes.50.8.1683 · Cited by 367
Glucose-induced β cell production of IL-1β contributes to glucotoxicity in human pancreatic islets
Maedler, K., Sergeev, P., Ris, F., Oberholzer, J., Joller‐Jemelka, H. I., Spinas, G. A., Kaiser, N., Halban, P. A., & Donath, M. Y. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15318 · Cited by 363
IKKα controls formation of the epidermis independently of NF-κB
Hu, Y., Baud, V., Oga, T., Kim, K. I., Yoshida, K., & Karin, M. (2001) · Nature · doi:10.1038/35070605 · Cited by 356
The deubiquitinase OTULIN is an essential negative regulator of inflammation and autoimmunity
Damgaard, R. B., Walker, J. A., Marco-Casanova, P., Morgan, N. V., Titheradge, H. L., Elliott, P. R., McHale, D., Maher, E. R., McKenzie, A. N. J., & Komander, D. (2016) · Cell · doi:10.1016/j.cell.2016.07.019 · Cited by 348
Precipitation of Autoimmune Diabetes With Anti-PD-1 Immunotherapy
Hughes, J., Vudattu, N., Sznol, M., Gettinger, S., Kluger, H., Lupsa, B., & Herold, K. C. (2015) · Diabetes Care · doi:10.2337/dc14-2349 · Cited by 347
Reactive Oxygen Species as Regulators of MDSC-Mediated Immune Suppression
Ohl, K., & Tenbrock, K. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02499 · Cited by 330
Johnston, A., Xing, X., Guzman, A. M., Riblett, M., Loyd, C. M., Ward, N. L., Wohn, C., Prens, E. P., Wang, F., Maier, L. E., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003162 · Cited by 319
Decision checkpoints in the thymus
Carpenter, A. C., & Bosselut, R. (2010) · Nature Immunology · doi:10.1038/ni.1887 · Cited by 306
Boisson, B., Laplantine, E., Dobbs, K., Cobat, A., Tarantino, N., Hazen, M., Lidov, H. G. W., Hopkins, G., Du, L., Belkadi, A., et al. (2015) · Journal of Experimental Medicine · doi:10.1084/jem.20141130 · Cited by 295
Self-citationSingh, N., Hopkins, S. J., Hulme, S., Galea, J. P., Hoadley, M., Vail, A., Hutchinson, P. J., Grainger, S., Rothwell, N. J., King, A. T., et al. (2014) · Journal of Neuroinflammation · doi:10.1186/1742-2094-11-1 · Cited by 284
CYLD, A20 and OTULIN deubiquitinases in NF-κB signaling and cell death: so similar, yet so different
Lork, M., Verhelst, K., & Beyaert, R. (2017) · Cell Death & Differentiation · doi:10.1038/cdd.2017.46 · Cited by 282
Vereecke, L., Sze, M., Guire, C. M., Rogiers, B., Chu, Y., Schmidt-Supprian, M., Pasparakis, M., Beyaert, R., & van Loo, G. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20092474 · Cited by 280
The linear ubiquitin-specific deubiquitinase gumby regulates angiogenesis
Rivkin, E., Almeida, S. M., Ceccarelli, D. F., Juang, Y.-C., MacLean, T. A., Srikumar, T., Huang, H., Dunham, W. H., Fukumura, R., Xie, G., et al. (2013) · Nature · doi:10.1038/nature12296 · Cited by 278
Zhou, Q., Yu, X., Demirkaya, E., Deuitch, N., Stone, D., Tsai, W. L., Kuehn, H. S., Wang, H., Yang, D., Park, Y. H., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1612594113 · Cited by 275
The Ubiquitin Modifying Enzyme A20 Restricts B Cell Survival and Prevents Autoimmunity
Tavares, R. M., Turer, E. E., Liu, C. L., Advincula, R., Scapini, P., Rhee, L., Barrera, J., Lowell, C. A., Utz, P. J., Malynn, B. A., et al. (2010) · Immunity · doi:10.1016/j.immuni.2010.07.017 · Cited by 271
PD-1/PD-L and autoimmunity: A growing relationship
Zamani, M. R., Aslani, S., Salmaninejad, A., Javan, M. R., & Rezaei, N. (2016) · Cellular Immunology · doi:10.1016/j.cellimm.2016.09.009 · Cited by 266
TNFR1-dependent cell death drives inflammation in Sharpin-deficient mice
Rickard, J. A., Anderton, H., Etemadi, N., Nachbur, U., Darding, M., Peltzer, N., Lalaoui, N., Lawlor, K. E., Vanyai, H., Hall, C., et al. (2014) · eLife · doi:10.7554/elife.03464 · Cited by 262
Chen, K., Coonrod, E. M., Kumánovics, A., Franks, Z. F., Durtschi, J. D., Margraf, R. L., Wu, W., Heikal, N. M., Augustine, N. H., Ridge, P. G., et al. (2013) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2013.09.009 · Cited by 261
Chen, D., Lan, J., Lin, F., & Hsieh, T. (2004) · PubMed · Cited by 259
c-Rel is required for the development of thymic Foxp3+ CD4 regulatory T cells
Isomura, I., Palmer, S., Grumont, R. J., Bunting, K., Hoyne, G., Wilkinson, N., Banerjee, A., Proietto, A., Gugasyan, R., Wu, L., et al. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20091411 · Cited by 253
Zhang, J., Stirling, B., Temmerman, S. T., Ma, C. A., Fuss, I. J., Derry, J. M. J., & Jain, A. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28746 · Cited by 245
Loss of B Cells in Patients with Heterozygous Mutations in IKAROS
Kuehn, H. S., Boisson, B., Cunningham-Rundles, C., Reichenbach, J., Stray-Pedersen, A., Gelfand, E. W., Maffucci, P., Pierce, K. R., Abbott, J. K., Voelkerding, K. V., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1512234 · Cited by 244
Haploinsufficiency of the NF-κB1 Subunit p50 in Common Variable Immunodeficiency
Fliegauf, M., L. Bryant, V., Frede, N., Slade, C., Woon, S.-T., Lehnert, K., Winzer, S., Bulashevska, A., Scerri, T., Leung, E., et al. (2015) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2015.07.008 · Cited by 243
TNFRSF1A mutations and autoinflammatory syndromes
Galon, J., Aksentijevich, I., McDermott, M. F., O’Shea, J. J., & Kastner, D. L. (2000) · Current Opinion in Immunology · doi:10.1016/s0952-7915(00)00124-2 · Cited by 243
Aeschlimann, F. A., Batu, E. D., Canna, S. W., Go, E., Gül, A., Hoffmann, P., Leavis, H. L., Ozen, S., Schwartz, D. M., Stone, D. L., et al. (2018) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2017-212403 · Cited by 233
Tuijnenburg, P., Lango Allen, H., Burns, S. O., Greene, D., Jansen, M. H., Staples, E., Stephens, J., Carss, K. J., Biasci, D., Baxendale, H., et al. (2018) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2018.01.039 · Cited by 233
Induction of autoimmune disease by deletion of CTLA-4 in mice in adulthood
Klocke, K., Sakaguchi, S., Holmdahl, R., & Wing, K. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1603892113 · Cited by 232
A20 critically controls microglia activation and inhibits inflammasome-dependent neuroinflammation
Voet, S., Mc Guire, C., Hagemeyer, N., Martens, A., Schroeder, A., Wieghofer, P., Daems, C., Staszewski, O., Vande Walle, L., Jordao, M. J. C., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04376-5 · Cited by 227
Grossmann, M. (2000) · The EMBO Journal · doi:10.1093/emboj/19.23.6351 · Cited by 227
McIntyre, K. W., Shuster, D. J., Gillooly, K. M., Dambach, D. M., Pattoli, M. A., Lu, P., Zhou, X., Qiu, Y., Zusi, F. C., & Burke, J. R. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11131 · Cited by 217
Germline hypomorphic CARD11 mutations in severe atopic disease
Ma, C. A., Stinson, J. R., Zhang, Y., Abbott, J. K., Weinreich, M. A., Hauk, P. J., Reynolds, P. R., Lyons, J. J., Nelson, C. G., Ruffo, E., et al. (2017) · Nature Genetics · doi:10.1038/ng.3898 · Cited by 217
The ubiquitin‐editing enzyme A20 requires RNF11 to downregulate NF‐κB signalling
Shembade, N., Parvatiyar, K., Harhaj, N. S., & Harhaj, E. W. (2009) · The EMBO Journal · doi:10.1038/emboj.2008.285 · Cited by 211
NF‐κB regulation: lessons from structures
Ghosh, G., Wang, V. Y., Huang, D., & Fusco, A. (2012) · Immunological Reviews · doi:10.1111/j.1600-065x.2012.01097.x · Cited by 208
LUBAC is essential for embryogenesis by preventing cell death and enabling haematopoiesis
Peltzer, N., Darding, M., Montinaro, A., Draber, P., Draberova, H., Kupka, S., Rieser, E., Fisher, A., Hutchinson, C., Taraborrelli, L., et al. (2018) · Nature · doi:10.1038/s41586-018-0064-8 · Cited by 206
Laplantine, E., Fontan, E., Chiaravalli, J., Lopez, T., Lakisic, G., Véron, M., Agou, F., & Israël, A. (2009) · The EMBO Journal · doi:10.1038/emboj.2009.241 · Cited by 201
Self-citationBantel, H. (2000) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(00)02153-5 · Cited by 200
OTULIN limits cell death and inflammation by deubiquitinating LUBAC
Heger, K., Wickliffe, K. E., Ndoja, A., Zhang, J., Murthy, A., Dugger, D. L., Maltzman, A., de Sousa e Melo, F., Hung, J., Zeng, Y., et al. (2018) · Nature · doi:10.1038/s41586-018-0256-2 · Cited by 199
Regulation of T cell development by the deubiquitinating enzyme CYLD
Reiley, W. W., Zhang, M., Jin, W., Losiewicz, M., Donohue, K. B., Norbury, C. C., & Sun, S.-C. (2006) · Nature Immunology · doi:10.1038/ni1315 · Cited by 198
NOD2 and inflammation: current insights
Negroni, A., Pierdomenico, M., Cucchiara, S., & Stronati, L. (2018) · Journal of Inflammation Research · doi:10.2147/jir.s137606 · Cited by 197
Serum cytokine profiles in patients with adult onset Still's disease.
Choi, J., Suh, C., Lee, Y. M., Suh, Y.-J., Lee, S.-K., Kim, S.-S., Nahm, D. H., & Park, H. (2003) · PubMed · Cited by 197
CARD–BCL-10–MALT1 signalling in protective and pathological immunity
Ruland, J., & Hartjes, L. (2019) · Nature Reviews Immunology · doi:10.1038/s41577-018-0087-2 · Cited by 196
Rood, M. J., Van Krugten, M. V., Zanelli, E., Van Der Linden, M. W., Keijsers, V., Schreuder, G. M. T., Verduyn, W., Westendorp, R. G. J., De Vries, R. R. P., Breedveld, F. C., et al. (2000) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200001)43:1<129::aid-anr16>3.0.co;2-s · Cited by 194
Human RIPK1 deficiency causes combined immunodeficiency and inflammatory bowel diseases
Li, Y., Führer, M., Bahrami, E., Socha, P., Klaudel-Dreszler, M., Bouzidi, A., Liu, Y., Lehle, A. S., Magg, T., Hollizeck, S., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1813582116 · Cited by 194
Protein kinase C theta (PKCθ): A key player in T cell life and death
HAYASHI, K., & ALTMAN, A. (2007) · Pharmacological Research · doi:10.1016/j.phrs.2007.04.009 · Cited by 193
NOD2 and Crohn’s Disease: Loss or Gain of Function?
Eckmann, L., & Karin, M. (2005) · Immunity · doi:10.1016/j.immuni.2005.06.004 · Cited by 185
Congenital B cell lymphocytosis explained by novel germline CARD11 mutations
Snow, A. L., Xiao, W., Stinson, J. R., Lu, W., Chaigne-Delalande, B., Zheng, L., Pittaluga, S., Matthews, H. F., Schmitz, R., Jhavar, S., et al. (2012) · Journal of Experimental Medicine · doi:10.1084/jem.20120831 · Cited by 184
Critical roles of c-Rel in autoimmune inflammation and helper T cell differentiation
Hilliard, B. A., Mason, N., Xu, L., Sun, J., Lamhamedi-Cherradi, S.-E., Liou, H.-C., Hunter, C., & Chen, Y. H. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215254 · Cited by 181
The Role of Nuclear Factor κB in the Interferon Response
Pfeffer, L. M. (2011) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2011.0028 · Cited by 178
Knight, J. S., Carmona-Rivera, C., & Kaplan, M. J. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00380 · Cited by 177
Norheim, K. B., Harboe, E., Gøransson, L. G., & Omdal, R. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030123 · Cited by 176
T‐cell selection in the thymus: a spatial and temporal perspective
Kurd, N. S., & Robey, E. A. (2016) · Immunological Reviews · doi:10.1111/imr.12398 · Cited by 174
Ubiquitin Makes Its Mark on Immune Regulation
Malynn, B. A., & Ma, A. I. (2010) · Immunity · doi:10.1016/j.immuni.2010.12.007 · Cited by 168
Type 2 innate immune responses and the natural helper cell
Koyasu, S., & Moro, K. (2011) · Immunology · doi:10.1111/j.1365-2567.2011.03413.x · Cited by 167
NF-κB Regulates PD-1 Expression in Macrophages
Bally, A. P. R., Lu, P., Tang, Y., Austin, J. W., Scharer, C. D., Ahmed, R., & Boss, J. M. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1402550 · Cited by 166
Modulation of NF-κB Signaling as a Therapeutic Target in Autoimmunity
Herrington, F., Carmody, R. J., & Goodyear, C. S. (2015) · SLAS DISCOVERY · doi:10.1177/1087057115617456 · Cited by 166
Nakanishi, H., Kawashima, Y., Kurima, K., Chae, J. J., Ross, A. M., Pinto-Patarroyo, G. P., Patel, S. K., Muskett, J. A., Ratay, J. S., Chattaraj, P., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1702946114 · Cited by 165
Baratin, M., Foray, C., Demaria, O., Habbeddine, M., Pollet, E., Maurizio, J., Verthuy, C., Davanture, S., Azukizawa, H., Flores-Langarica, A., et al. (2015) · Immunity · doi:10.1016/j.immuni.2015.03.003 · Cited by 163
NOD1 and NOD2: Beyond Peptidoglycan Sensing
Keestra-Gounder, A. M., & Tsolis, R. M. (2017) · Trends in Immunology · doi:10.1016/j.it.2017.07.004 · Cited by 163
Caso, F., Galozzi, P., Costa, L., Sfriso, P., Cantarini, L., & Punzi, L. (2015) · RMD Open · doi:10.1136/rmdopen-2015-000097 · Cited by 162
Jounai, N., Kobiyama, K., Takeshita, F., & Ishii, K. J. (2013) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2012.00168 · Cited by 162
Klemann, C., Camacho-Ordóñez, N., Yang, L., Eskandarian, Z., Rojas‐Restrepo, J., Frede, N., Bulashevska, A., Heeg, M., Al-Ddafari, M. S., Premm, J., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00297 · Cited by 162
Savinova, O. V., Hoffmann, A., & Ghosh, G. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.04.033 · Cited by 159
Hayasaka, N., Takada, K., Nakamura, H., Arihara, Y., Kawano, Y., Osuga, T., Murase, K., Kikuchi, S., Iyama, S., Emori, M., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-42300-z · Cited by 156
Kolly, L., Busso, N., von Scheven-Gête, A., Bagnoud, N., Moix, I., Holzinger, D., Simon, G., Ives, A., Guarda, G., So, A. K.-L., et al. (2012) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2012.07.043 · Cited by 154
Turvey, S. E., Durandy, A., Fischer, A., Fung, S., Geha, R. S., Gewies, A., Giese, T., Greil, J., Keller, B., McKinnon, M. L., et al. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.06.015 · Cited by 153
NF-κB/Rel/IκB: Implications in gastrointestinal diseases
Schmid, R. M., & Adler, G. (2000) · Gastroenterology · doi:10.1016/s0016-5085(00)70374-x · Cited by 153
Negative regulation of NF-κB p65 activity by serine 536 phosphorylation
Pradère, J., Hernandez, C., Koppe, C., Friedman, R. A., Luedde, T., & Schwabe, R. F. (2016) · Science Signaling · doi:10.1126/scisignal.aab2820 · Cited by 153
Kelsall, I. R., Zhang, J., Knebel, A., Arthur, J. S. C., & Cohen, P. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1905873116 · Cited by 153
Prescott, J. A., & Cook, S. J. (2018) · Cells · doi:10.3390/cells7090115 · Cited by 151
Inhibitory kappa B kinases as targets for pharmacological regulation
Gamble, C., McIntosh, K., Scott, R., Ho, K. H., Plevin, R. J., & Paul, A. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01608.x · Cited by 150
CYLD negatively regulates transforming growth factor-β-signalling via deubiquitinating Akt
Lim, J. H., Jono, H., Komatsu, K., Woo, C.-H., Lee, J., Miyata, M., Matsuno, T., Xu, X., Huang, Y., Zhang, W., et al. (2012) · Nature Communications · doi:10.1038/ncomms1776 · Cited by 149
CTLA-4 and autoimmunity: New insights into the dual regulator of tolerance
Romo‐Tena, J., Gómez‐Martín, D., & Alcocer-Varela, J. C. (2013) · Autoimmunity Reviews · doi:10.1016/j.autrev.2013.07.002 · Cited by 148
Magne, D., Palmer, G., Barton, J. L., Mézin, F., Talabot‐Ayer, D., Bas, S., Duffy, T., Noger, M., Guerne, P., Nicklin, M. J. H., et al. (2006) · Arthritis Research & Therapy · doi:10.1186/ar1946 · Cited by 146
Linear ubiquitination in immunity
Shimizu, Y., Taraborrelli, L., & Walczak, H. (2015) · Immunological Reviews · doi:10.1111/imr.12309 · Cited by 144
Chang, J., Xiao, Y., Hu, H., Jin, J., Yu, J., Zhou, X., Wu, X., Johnson, H. M., Akira, S., Pasparakis, M., et al. (2012) · Nature Immunology · doi:10.1038/ni.2267 · Cited by 143
NF-κB2 is required for the establishment of central tolerance through an Aire-dependent pathway
Zhu, M., Chin, R., Christiansen, P. A., Lo, J. C., Liu, X., Ware, C. F., Siebenlist, U. K., & Fu, Y. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28326 · Cited by 143
A20 controls intestinal homeostasis through cell-specific activities
Vereecke, L., Vieira‐Silva, S., Billiet, T., van Es, J. H., Guire, C. M., Slowicka, K., Sze, M., van den Born, M., Hertogh, G. D., Clevers, H. C., et al. (2014) · Nature Communications · doi:10.1038/ncomms6103 · Cited by 142
Damaging heterozygous mutations in NFKB1 lead to diverse immunologic phenotypes
Kaustio, M., Haapaniemi, E. M., Göös, H., Hautala, T., Park, G., Syrjänen, J., Einarsdóttir, E., Sahu, B., Kilpinen, S., Rounioja, S., et al. (2017) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2016.10.054 · Cited by 142
Sugiura, K. (2014) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2014.02.006 · Cited by 141
Maedler, K., Fontana, A., Ris, F., Sergeev, P., Toso, C., Oberholzer, J., Lehmann, R., Bachmann, F., Tasinato, A., Spinas, G. A., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.122686299 · Cited by 140
Gomez, A. M., Vrolix, K., Martínez‐Martínez, P., Molenaar, P. C., Phernambucq, M., van der Esch, E., Duimel, H., Verheyen, F., Voll, R. E., Manz, R. A., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1002539 · Cited by 140
Crucial Role for BAFF-BAFF-R Signaling in the Survival and Maintenance of Mature B Cells
Rauch, M., Tussiwand, R., Bosco, N., & Rolink, A. G. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005456 · Cited by 139
MLN120B, a Novel IκB Kinase β Inhibitor, Blocks Multiple Myeloma Cell Growth In vitro and In vivo
Hideshima, T., Neri, P. E., Tassone, P., Yasui, H., Ishitsuka, K., Raje, N. S., Chauhan, D., Podar, K., Mitsiades, C. S., Dang, L., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2501 · Cited by 136
Werth, V. P., Zhang, W., Dortzbach, K., & Sullivan, K. E. (2000) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2000.00118.x · Cited by 136
Defective immune responses in mice lacking LUBAC‐mediated linear ubiquitination in B cells
Sasaki, Y., Sano, S., Nakahara, M., Murata, S., Kometani, K., Aiba, Y., Sakamoto, S., Watanabe, Y., Tanaka, K., Kurosaki, T., et al. (2013) · The EMBO Journal · doi:10.1038/emboj.2013.184 · Cited by 133
Haploinsufficiency of A20 causes autoinflammatory and autoimmune disorders
Kadowaki, T., Ohnishi, H., Kawamoto, N., Hori, T., Nishimura, K., Kobayashi, C., Shigemura, T., Ogata, S., Inoue, Y., Kawai, T., et al. (2017) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2017.10.039 · Cited by 133
A c-Rel subdomain responsible for enhanced DNA-binding affinity and selective gene activationPreprint
Sanjabi, S., Williams, K. J., Saccani, S., Zhou, L., Hoffmann, A. A., Ghosh, G., Gerondakis, S., Natoli, G., & Smale, S. T. (2005) · Genes & Development · doi:10.1101/gad.1329805 · Cited by 132
The NF-κB regulator MALT1 determines the encephalitogenic potential of Th17 cells
Brüstle, A., Brenner, D., Knobbe-Thomsen, C. B., Lang, P. A., Virtanen, C., Hershenfield, B. M., Reardon, C., Lacher, S. M., Ruland, J., Ohashi, P. S., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci63528 · Cited by 131
Intestinal Inflammation and Dysregulated Immunity in Patients With Inherited Caspase-8 Deficiency
Lehle, A. S., Farin, H. F., Marquardt, B., Michels, B. E., Magg, T., Li, Y., Liu, Y., Ghalandary, M., Lammens, K., Hollizeck, S., et al. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.09.041 · Cited by 130
Human RELA haploinsufficiency results in autosomal-dominant chronic mucocutaneous ulceration
Badran, Y. R., Dedeoğlu, F., Leyva-Castillo, J. M., Bainter, W., Ohsumi, T. K., Bousvaros, A., Goldsmith, J. D., Geha, R. S., & Chou, J. S. (2017) · The Journal of Experimental Medicine · doi:10.1084/jem.20160724 · Cited by 129
Li, Q., Lee, C. H., Peters, L. A., Mastropaolo, L. A., Thoeni, C. E., Elkadri, A. A., Schwerd, T., Zhu, J., Zhang, B., Zhao, Y., et al. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.01.031 · Cited by 124
TLR7/TLR9- and B Cell Receptor-Signaling Crosstalk: Promotion of Potentially Dangerous B Cells
Suthers, A. N., & Sarantopoulos, S. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00775 · Cited by 123
Takiuchi, T., Nakagawa, T., Tamiya, H., Fujita, H., Sasaki, Y., Saeki, Y., Takeda, H., Sawasaki, T., Buchberger, A., Kimura, T., et al. (2014) · Genes to Cells · doi:10.1111/gtc.12128 · Cited by 116
Lee, C. E., Fulcher, D. A., Whittle, B., Chand, R., Fewings, N., Field, M. A., Andrews, D., Goodnow, C. C., & Cook, M. (2014) · Blood · doi:10.1182/blood-2014-06-578542 · Cited by 116
Jing, N., Du, Y., Chen, X., Bai, Q., Wang, Y., Zhang, X., Zhu, N., Zhang, J., Hou, J., Wang, Q. L., et al. (2014) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0464 · Cited by 111
BCL3 Encodes a Nuclear Protein Which Can Alter the Subcellular Location of NF-κB Proteins
Zhang, Q., DiDonato, J. A., Karin, M., & McKeithan, T. W. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.6.3915-3926.1994 · Cited by 108
NF-κB1 Haploinsufficiency Causing Immunodeficiency and EBV-Driven Lymphoproliferation
Boztug, H., Hirschmugl, T., Holter, W., Lakatos, K., Kager, L., Trapin, D., Pickl, W. F., Förster‐Waldl, E., & Boztuǧ, K. (2016) · Journal of Clinical Immunology · doi:10.1007/s10875-016-0306-1 · Cited by 107
Takagi, M., Ogata, S., Ueno, H., Yoshida, K., Yeh, T., Hoshino, A., Piao, J., Yamashita, M., Nanya, M., Okano, T., et al. (2016) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2016.09.038 · Cited by 105
Nuclear Factor-kappaB in Autoimmunity: Man and Mouse
Miraghazadeh, B., & Cook, M. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00613 · Cited by 105
Kontzias, A., & Efthimiou, P. (2008) · Drugs · doi:10.2165/00003495-200868030-00005 · Cited by 104
LUBAC prevents lethal dermatitis by inhibiting cell death induced by TNF, TRAIL and CD95L
Taraborrelli, L., Peltzer, N., Montinaro, A., Kupka, S., Rieser, E., Hartwig, T., Sarr, A., Darding, M., Dráber, P., Haas, T. L., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-06155-8 · Cited by 103
Walsh, E. R., Pisitkun, P., Voynova, E., Deane, J. A., Scott, B. L., Caspi, R. R., & Bolland, S. M. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1209372109 · Cited by 101
Wang, X., Deckert, M., Xuân, N. T., Nishanth, G., Just, S., Waisman, A., Naumann, M., & Schlüter, D. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1183-9 · Cited by 98
Kensche, T., Tokunaga, F., Ikeda, F., Gotō, E., Iwaï, K., & Đikić, I. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.347195 · Cited by 97
Fujita, H., Tokunaga, A., Shimizu, S., Whiting, A. L., Aguilar-Alonso, F. A., Takagi, K., Walinda, E., Sasaki, Y., Shimokawa, T., Mizushima, T., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.03.112 · Cited by 97
Kuehn, H. S., Niemela, J. E., Sreedhara, K., Stoddard, J. L., Grossman, J. K., Wysocki, C., de la Morena, M. T., Garofalo, M. E., Inlora, J., Snyder, M. P., et al. (2017) · Blood · doi:10.1182/blood-2017-05-782177 · Cited by 95
The effects of RelB deficiency on lymphocyte development and function
Sharfe, N., Merico, D., Karanxha, A., Macdonald, C., Dadi, H., Ngan, B., Herbrick, J.-A., & Roifman, C. M. (2015) · Journal of Autoimmunity · doi:10.1016/j.jaut.2015.09.001 · Cited by 94
Liedtke, C., & Trautwein, C. (2011) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2011.10.001 · Cited by 91
Shimane, K., Kochi, Y., Horita, T., Ikari, K., Amano, H., Hirakata, M., Okamoto, A., Yamada, R., Myouzen, K., Suzuki, A., et al. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27190 · Cited by 90
Generation of peripheral B cells occurs via two spatially and temporally distinct pathways
Lindsley, R. C., Thomas, M., Srivastava, B., & Allman, D. (2006) · Blood · doi:10.1182/blood-2006-04-018085 · Cited by 87
Germline CARD11 Mutation in a Patient with Severe Congenital B Cell Lymphocytosis
Brohl, A. S., Stinson, J. R., Su, H. C., Badgett, T., JENNINGS, C. D., Sukumar, G., Sindiri, S., Wang, W., Kardava, L., Moir, S. L., et al. (2014) · Journal of Clinical Immunology · doi:10.1007/s10875-014-0106-4 · Cited by 84
Potter, C., Cordell, H. J., Barton, A. C., Daly, A. K., Hyrich, K. L., Mann, D. A., Morgan, A. W., Wilson, A. G., & Isaacs, J. D. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2009.117309 · Cited by 84
Cutting Edge: Pivotal Function of Ubc13 in Thymocyte TCR Signaling
Yamamoto, M., Sato, S., Saitoh, T., Sakurai, H., Uematsu, S., Kawai, T., Ishii, K. J., Takeuchi, O., & Akira, S. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.11.7520 · Cited by 84
Ikaros prevents autoimmunity by controlling anergy and Toll-like receptor signaling in B cells
Schwickert, T. A., Tagoh, H., Schindler, K., Fischer, M., Jaritz, M., & Busslinger, M. (2019) · Nature Immunology · doi:10.1038/s41590-019-0490-2 · Cited by 82
Derudder, E., Cadera, E. J., Vahl, J. C., Wang, J. H., Fox, C. J., Zha, S., Loo, G., Pasparakis, M., Schlissel, M. S., Schmidt‐Supprian, M., et al. (2009) · Nature Immunology · doi:10.1038/ni.1732 · Cited by 80
B-cell tolerance and autoimmunity
Tsubata, T., & Honjo, T. (2017) · F1000Research · doi:10.12688/f1000research.10583.1 · Cited by 79
Riemann, M., Andreas, N., Fedoseeva, M., Meier, E., Weih, D., Freytag, H., Schmidt‐Ullrich, R., Klein, U., Wang, Z., & Weih, F. (2017) · Journal of Autoimmunity · doi:10.1016/j.jaut.2017.03.007 · Cited by 79
Cited by
Free radicals and their impact on health and antioxidant defenses: a review
Chandimali, N., Bak, S. G., Park, E. H., Lim, H.-J., Won, Y.-S., Kim, E.-K., Park, S.-I., & Lee, S. J. (2025) · Cell Death Discovery · doi:10.1038/s41420-024-02278-8 · Cited by 669
NF‐κB signaling in inflammation and cancer
Zhang, T., Ma, C., Zhang, Z., Zhang, H., & Hu, H. (2021) · MedComm · doi:10.1002/mco2.104 · Cited by 574
NF-κB in inflammation and cancer
Mao, H., Zhao, X., & Sun, S.-C. (2025) · Cellular & Molecular Immunology · doi:10.1038/s41423-025-01310-w · Cited by 489
Connecting aging biology and inflammation in the omics era
Walker, K. A., Basisty, N., Wilson, D. M., & Ferrucci, L. (2022) · Journal of Clinical Investigation · doi:10.1172/jci158448 · Cited by 189
Zeng, J., Bao, T., Yang, K., Zhu, X., Wang, S., Xiang, W., Ge, A., Zeng, L., & Ge, J. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1047550 · Cited by 175
Metadata
- Authors
- Barnabei, L., Laplantine, E., Mbongo, W., Rieux-Laucat, F., & Weil, R.
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2021-08-09
- Volume
- 12
- Pages
- 716469-716469
- ISSN
- 1664-3224 (ISSN-L)
- OpenAlex
- W3192348655
- Cited by
- 630
- References
- 248
- FWCI
- 29.61
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.